Related Experiment Videos
Amniotic epithelial cells transform into neuron-like cells in the ischemic brain
1Department of Neurosurgery, Juntendo University School of Medicine, Hongo 2-1-1, Bunkyo-ku, Tokyo 113-8421, Japan.
Neuroreport
|December 14, 2001
Summary
Rat amniotic epithelial (RAE) cells show potential for treating brain ischemia. Transplanted RAE cells survived and integrated into damaged brain regions, suggesting therapeutic applications for neuronal disorders.
Area of Science:
- Neuroscience
- Regenerative Medicine
- Cell Biology
Background:
- Brain ischemia leads to significant neuronal damage and functional deficits.
- Current therapies for ischemic brain damage are limited.
- Neural stem cells offer potential for brain repair but face challenges.
Purpose of the Study:
- To evaluate rat amniotic epithelial (RAE) cells as a potential donor cell source for transplantation therapy in brain ischemia.
- To assess the survival, migration, and differentiation potential of RAE cells in an ischemic brain environment.
Main Methods:
- In vitro characterization of RAE cells for neuronal and neural stem cell markers (neurofilament, microtubule-associated protein 2, nestin).
- Reverse transcription polymerase chain reaction (RT-PCR) to detect nestin mRNA expression.
- Intracerebral transplantation of RAE cells into the hippocampus of gerbils subjected to bilateral carotid artery occlusion (brain ischemia model).
- Post-transplantation survival and migration assessment of grafted cells.
Main Results:
- RAE cells expressed neuronal and neural stem cell markers in vitro.
- RAE cells expressed nestin mRNA.
- Transplanted RAE cells migrated to the CA1 pyramidal layer, a region affected by selective neuronal death.
- Grafted RAE cells survived for five weeks, exhibiting survival patterns similar to host CA1 pyramidal neurons.
Conclusions:
- Rat amniotic epithelial cells possess characteristics of neural stem cells.
- Intracerebral transplantation of RAE cells demonstrates survival and integration in an ischemic brain.
- RAE cells hold therapeutic promise for treating ischemic brain damage and neuronal disorders.